Thursday, November 26

Russian coronavirus vaccine: Sputnik V’s “92% effectiveness” according to its manufacturers (and how it compares to Pfizer’s)


  • Drafting
  • BBC World News

Caption,

According to its developers, preliminary results of its clinical tests point to an effectiveness of 92% for the Sputnik V vaccine.

It seems like another piece of good news in the race for a coronavirus vaccine, but like many others it should also be viewed with caution.

And it is that according to a statement published on Wednesday by the developers of the Russian vaccine Sputnik V, the preliminary results of the last phase of clinical tests of the same suggest that it has an effectiveness of 92%.

The estimate is based on preliminary data from a Phase III clinical trial involving 40,000 volunteers, of whom 16,000 have already received the two doses that make up the vaccine.

More specifically, it was “calculated based on the 20 confirmed cases of covid-19 divided between vaccinated individuals and those who received the placebo, “the statement read, signed by the Gamalaya Center for Research in Epidemiology and Microbiology and the Russian Direct Investment Fund, RDIF.

style="display:block" data-ad-client="ca-pub-3066188993566428" data-ad-slot="4073357244" data-ad-format="auto" data-full-width-responsive="true">
www.bbc.com
style="display:block" data-ad-client="ca-pub-3066188993566428" data-ad-slot="4073357244" data-ad-format="auto" data-full-width-responsive="true">

Leave a Reply

Your email address will not be published. Required fields are marked *